Institutional Ownership Ascendis Pharma A/S (ASND)
This table provides information about the institutional ownership of Ascendis Pharma A/S (ASND). We have compiled data on the 318 institutions that hold shares in the stock, with a total of 65 Million shares, which have been reported (via 13F filing form) to have a value of $13.3 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Spyglass Capital Management LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
388,647
shares
|
$79.4 Million
4.28% of portfolio
|
Q3 2025
New holding
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2025 Q3 2025 |
375,899
shares
|
$76.8 Million
0.02% of portfolio
|
Q3 2025
Reduced 0.48%
|
|
|
Macquarie Group LTD
Australia, C3 |
Nov 13, 2025 Q3 2025 |
309,539
shares
|
$63.3 Million
0.07% of portfolio
|
Q3 2025
Added 165.16%
|
|
|
Td Asset Management Inc
|
Nov 10, 2025 Q3 2025 |
296,346
shares
|
$60.6 Million
0.05% of portfolio
|
Q3 2025
Added 1.46%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
292,396
shares
|
$59.8 Million
0.0% of portfolio
|
Q3 2025
Added 57.95%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
290,172
shares
|
$59.3 Million
0.06% of portfolio
|
Q3 2025
Added 44.33%
|
|
|
Camber Capital Management LP
Boston, MA |
Aug 14, 2025 Q2 2025 |
250,000
shares
|
$51.1 Million
4.25% of portfolio
|
Q2 2025
Reduced 28.57%
|
|
|
Siren, L.L.C.
New York, NY |
Nov 13, 2025 Q3 2025 |
235,862
shares
|
$48.2 Million
1.83% of portfolio
|
Q3 2025
Reduced 4.1%
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Nov 14, 2025 Q3 2025 |
234,397
shares
|
$47.9 Million
0.17% of portfolio
|
Q3 2025
Reduced 10.97%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
214,500
shares
|
$43.8 Million
2.85% of portfolio
|
Q3 2025
Reduced 1.15%
|
|
|
Victory Capital Management Inc
|
Nov 12, 2025 Q3 2025 |
208,931
shares
|
$42.7 Million
0.03% of portfolio
|
Q3 2025
Reduced 4.65%
|
|
|
Sei Investments CO
Oaks, PA |
Nov 13, 2025 Q3 2025 |
205,319
shares
|
$42 Million
0.05% of portfolio
|
Q3 2025
Reduced 13.21%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
195,204
shares
|
$39.9 Million
0.01% of portfolio
|
Q3 2025
Added 135.87%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
191,905
shares
|
$39.2 Million
1.3% of portfolio
|
Q3 2025
Added 457.86%
|
|
|
Allspring Global Investments Holdings, LLC
|
Oct 20, 2025 Q3 2025 |
191,672
shares
|
$39.2 Million
0.07% of portfolio
|
Q3 2025
Reduced 4.29%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
Nov 07, 2025 Q3 2025 |
189,654
shares
|
$38.8 Million
0.1% of portfolio
|
Q3 2025
Reduced 31.53%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
183,886
shares
|
$37.6 Million
0.06% of portfolio
|
Q3 2025
Added 5803.24%
|
|
|
Driehaus Capital Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
179,168
shares
|
$36.6 Million
0.3% of portfolio
|
Q3 2025
Reduced 8.17%
|
|
|
Candriam S.C.A.
|
Nov 05, 2025 Q3 2025 |
178,956
shares
|
$36.6 Million
0.19% of portfolio
|
Q3 2025
Reduced 8.28%
|
|
|
Ars Investment Partners, LLC
|
Oct 15, 2025 Q3 2025 |
175,667
shares
|
$35.9 Million
3.04% of portfolio
|
Q3 2025
Reduced 16.32%
|
|
|
Tri Locum Partners LP
New York, NY |
Nov 14, 2025 Q3 2025 |
174,829
shares
|
$35.7 Million
9.55% of portfolio
|
Q3 2025
Added 18.41%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2025 Q3 2025 |
174,603
shares
|
$35.7 Million
0.02% of portfolio
|
Q3 2025
Added 139.55%
|
|
|
Fred Alger Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
170,701
shares
|
$34.9 Million
0.15% of portfolio
|
Q3 2025
Added 4398.05%
|
|
|
Q Global Advisors, LLC
Fort Worth, TX |
Nov 13, 2025 Q3 2025 |
170,000
shares
|
$34.7 Million
53.09% of portfolio
|
Q3 2025
Reduced 33.33%
|
|
|
New York State Common Retirement Fund
|
Nov 03, 2025 Q3 2025 |
169,894
shares
|
$34.7 Million
0.05% of portfolio
|
Q3 2025
Reduced 6.94%
|
|